Cited by 141Organ Transplantation Techniques and OutcomesLiver Disease and TransplantationArtificial Intelligence in Healthcare

Development and Validation of an Optimized Prediction of Mortality for Candidates Awaiting Liver Transplantation

Open access
Bertsimas, Dimitris, Kung, Jerry, Trichakis, Nikolaos, Wang, Yuchen, Hirose, Ryutaro, Vagefi, Parsia A.·2019·American Journal of Transplantation

Abstract

Since 2002, the Model for End-Stage Liver Disease (MELD) has been used to rank liver transplant candidates. However, despite numerous revisions, MELD allocation still does not allow for equitable access to all waitlisted candidates. An optimized prediction of mortality (OPOM) was developed (http://www.opom.online) utilizing machine-learning optimal classification tree models trained to predict a candidate's 3-month waitlist mortality or removal utilizing the Standard Transplant Analysis and Research (STAR) dataset. The Liver Simulated Allocation Model (LSAM) was then used to compare OPOM to MELD-based allocation. Out-of-sample area under the curve (AUC) was also calculated for candidate groups of increasing disease severity. OPOM allocation, when compared to MELD, reduced mortality on average by 417.96 (406.8-428.4) deaths every year in LSAM analysis. Improved survival was noted across all candidate demographics, diagnoses, and geographic regions. OPOM delivered a substantially higher AUC across all disease severity groups. OPOM more accurately and objectively prioritizes candidates for liver transplantation based on disease severity, allowing for more equitable allocation of livers with a resultant significant number of additional lives saved every year. These data demonstrate the potential of machine learning technology to help guide clinical practice, and potentially guide national policy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/ajt.15172

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Heimbach JK, Hirose R, Stock PG, et al. Delayed hepatocellular carcinoma model for end-stage l i ver di sease excepti on score i mproves di spari ty i n access to l i ver transplant in the United States. Hepatology 2015;61:1643-1650.

Cited by

Sorted by citations

Authors
Bertsimas, D., Kung, J., Trichakis, N., Wang, Y., Hirose, R., & Vagefi, P. A.
Affiliations
  • Massachusetts Institute of Technology (US)
  • University of California, San Francisco (US)
  • The University of Texas Southwestern Medical Center (US)
Corresponding author
Bertsimas, Dimitris
Venue
American Journal of Transplantation
Publisher
Elsevier BV
Published
2019-04
Volume
19
Issue
4
Pages
1109-1118
ISSN
1600-6135 (ISSN-L)
OpenAlex
W2899525417
Cited by
141
References
18
Citations by year
2026: 18 · 2025: 20 · 2024: 33 · 2023: 17 · 2022: 15 · 2021: 15 · 2020: 15 · 2019: 7
FWCI
9.62
Type
journal article
Language
en
Open access
Locations
  • American Journal of Transplantation (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
Topics
  • Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
  • Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
Keywords
liver transplantation, transplant candidate prioritization, mortality prediction, Model for End-Stage Liver Disease, classification trees, waitlist mortality, disease severity, machine learning
MeSH terms
Machine Learning, Female, Humans, Liver Diseases, Male, Waiting Lists, Models, Statistical, Liver Transplantation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review